KORU Medical Systems, Inc. financial data

Symbol
KRMD on Nasdaq
Location
Mahwah, NJ
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 12 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 254% % -22%
Quick Ratio 51% % -3.3%
Debt-to-equity 63% % 23%
Return On Equity -16% % 53%
Return On Assets -9.8% % 56%
Operating Margin -7.2% % 62%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 46,370,432 shares 0.9%
Common Stock, Shares, Outstanding 46,370,432 shares 0.9%
Entity Public Float $119,084,035 USD 43%
Common Stock, Value, Issued $497,909 USD 0.84%
Weighted Average Number of Shares Outstanding, Basic 45,981,826 shares 0.59%
Weighted Average Number of Shares Outstanding, Diluted 46,187,077 shares 0.84%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $41,127,366 USD 22%
Research and Development Expense $4,387,214 USD -17%
Operating Income (Loss) $2,972,442 USD 54%
Nonoperating Income (Expense) $356,406 USD -6.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $2,616,036 USD 57%
Income Tax Expense (Benefit) $150,000 USD
Net Income (Loss) Attributable to Parent $2,637,926 USD 57%
Earnings Per Share, Basic -0.14 USD/shares 33%
Earnings Per Share, Diluted -0.06 USD/shares 54%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $8,872,212 USD -7.4%
Accounts Receivable, after Allowance for Credit Loss, Current $6,209,950 USD 8.6%
Inventory, Net $3,678,131 USD 31%
Assets, Current $19,988,790 USD 4.5%
Property, Plant and Equipment, Net $4,471,386 USD 4.2%
Operating Lease, Right-of-Use Asset $2,956,192 USD -0.34%
Other Assets, Noncurrent $98,970 USD 0%
Assets $28,200,179 USD 3.6%
Accounts Payable, Current $2,267,473 USD 37%
Employee-related Liabilities, Current $531,972 USD -34%
Accrued Liabilities, Current $4,828,830 USD 23%
Liabilities, Current $8,194,358 USD 14%
Operating Lease, Liability, Noncurrent $2,879,224 USD -4%
Liabilities $11,152,257 USD 7.2%
Retained Earnings (Accumulated Deficit) $32,016,832 USD -9%
Stockholders' Equity Attributable to Parent $17,047,922 USD 1.4%
Liabilities and Equity $28,200,179 USD 3.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $237,467 USD 32%
Net Cash Provided by (Used in) Financing Activities $160,808 USD 12%
Net Cash Provided by (Used in) Investing Activities $446,838 USD -236%
Common Stock, Shares Authorized 75,000,000 shares 0%
Common Stock, Shares, Issued 49,790,934 shares 0.84%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $845,113 USD -28%
Interest Paid, Excluding Capitalized Interest, Operating Activities $5,385 USD -56%
Deferred Tax Assets, Valuation Allowance $7,053,948 USD -0.38%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross $8,416,183 USD 1.2%
Operating Lease, Liability $3,292,672 USD -3.2%
Depreciation $227,785 USD 14%
Property, Plant and Equipment, Gross $8,538,579 USD 10%
Operating Lease, Liability, Current $413,448 USD 3.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two $554,475 USD 3.8%
Lessee, Operating Lease, Liability, to be Paid, Year One $539,329 USD 1%
Deferred Income Tax Expense (Benefit) $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Three $557,286 USD 4.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four $553,759 USD 6.3%
Operating Lease, Payments $129,363 USD 7.5%
Depreciation, Depletion and Amortization $810,500 USD -8.8%
Deferred Tax Assets, Net of Valuation Allowance $1,362,235 USD 10%